Apogenix AG: Strong Quality of Life Data for Apogenix’ Asunercept Published in Journal of Neuro-Oncology

InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa

InflaRx Reports Positive Results from the Open Label Extension Part of the SHINE Study for IFX-1 in Hidradenitis Suppurativa

Verona Pharma plc: Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019

Medigene AG: Medigene to present on neoantigens as targets for TCR-T cell-based therapies at 2019 SITC Annual Meeting

ORYX Provides Strategic Update on the Clinical Development of Oncolytic Virotherapy ParvOryx

Atriva Therapeutics to present at the BIO-Europe in Hamburg

ORYX Announces Positive Phase I/IIa Data for Oncolytic Virus ParvOryx Demonstrating Safety, Anti-tumor Effects, Partial Responses and Prolonged Overall Survival in Metastatic, Inoperable Pancreatic Cancer

Medigene AG: Medigene participates at upcoming conferences

Newron Initiates Outreach on First Global Rett Syndrome Burden of Illness Survey in Collaboration with the Rett Community